Stocks and Investing
Stocks and Investing
Tue, December 12, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, December 11, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Maintained (ABT) at Strong Buy with Increased Target to $123 on, Dec 11th, 2023
Joanne Wuensch of Citigroup, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $122 to $123 on, Dec 11th, 2023.
Joanne has made no other calls on ABT in the last 4 months.
There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 1 agrees with Joanne's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $107 on, Thursday, October 19th, 2023
These are the ratings of the 3 analyists that currently disagree with Joanne
- Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $110 on, Thursday, October 19th, 2023
- Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $116 on, Thursday, October 19th, 2023
- Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $133 on, Thursday, October 19th, 2023
Contributing Sources